Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Owlstone, Mayo Clinic ink collaboration
June 2017
SHARING OPTIONS:

CAMBRIDGE, U.K.—Diagnostic company Owlstone Medical has established a collaboration with the Mayo Clinic, under which its FAIMS technology will be applied in a clinical trial to determine its utility as a rapid, point-of-care test for non-invasive assessment of the adequacy of bowel preparation before a colonoscopy. Of the roughly 14 million colonoscopies conducted in the United States every year, it’s estimated that as many as a quarter have inadequate preparation, which can result in the need for repeat procedures or an increased risk of missing a needed diagnosis. A pilot study demonstrated that Owlstone Medical’s technology was capable of rapid, effective identification of inadequately prepared patients with 100-percent sensitivity and 80-percent specificity. The larger clinical trial will determine if the FAIMS technology can be used as a pre-endoscopic test to ensure colonoscopies are only performed on adequately prepared patients.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.